United States
# |
Name |
Price to Sales Ratio (P/S) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
8.48 |
Jan. 14, 2025 | USD 39.22 | 1.63% |
|
United States |
|
2 |
4.34 |
Jan. 14, 2025 | USD 627.71 | 1.49% |
|
United States |
|
3 |
3.97 |
Jan. 14, 2025 | USD 144.75 | 0.19% |
|
United States |
|
4 |
3.05 |
Jan. 14, 2025 | USD 17.68 | 0.68% |
|
United States |
|
5 |
2.50 |
Jan. 14, 2025 | USD 72.63 | 1.31% |
|
United States |
|
6 |
2.34 |
Jan. 14, 2025 | USD 95.99 | -0.72% |
|
United States |
|
7 |
2.21 |
Jan. 14, 2025 | USD 14.98 | -0.13% |
|
United States |
|
8 |
2.05 |
Jan. 14, 2025 | USD 54.16 | 0.43% |
|
United States |
|
9 |
2.00 |
Jan. 14, 2025 | USD 4.15 | -1.66% |
|
United States |
|
10 |
1.84 |
Jan. 14, 2025 | USD 42.32 | NA |
|
United States |
|
11 |
1.65 |
Jan. 14, 2025 | USD 404.06 | 0.03% |
|
United States |
|
12 |
1.55 |
Jan. 14, 2025 | USD 5.67 | 2.35% |
|
United States |
|
13 |
1.49 |
Jan. 14, 2025 | USD 12.40 | -1.20% |
|
United States |
|
14 |
1.15 |
Jan. 14, 2025 | USD 35.65 | -0.17% |
|
United States |
|
15 |
1.07 |
Jan. 14, 2025 | USD 36.79 | 0.03% |
|
United States |
|
16 |
0.93 |
Jan. 14, 2025 | USD 11.72 | -0.68% |
|
United States |
|
17 |
0.72 |
Jan. 14, 2025 | USD 38.98 | 0.72% |
|
United States |
|
18 |
0.56 |
Jan. 14, 2025 | USD 11.50 | 1.23% |
|
United States |
|
19 |
0.45 |
Jan. 14, 2025 | USD 8.97 | -1.75% |
|
United States |
|
20 |
0.39 |
Jan. 14, 2025 | USD 4.88 | 0.62% |
|
United States |
|
21 |
0.38 |
Jan. 14, 2025 | USD 66.75 | 0.48% |
|
United States |
|
22 |
0.29 |
Jan. 14, 2025 | USD 17.80 | 3.01% |
|
United States |
|
23 |
0.29 |
Jan. 14, 2025 | USD 59.92 | 0.72% |
|
United States |
|
24 |
0.23 |
Jan. 14, 2025 | USD 1.05 | -7.08% |
|
United States |
|
25 |
0.23 |
Jan. 14, 2025 | USD 593.73 | 1.48% |
|
United States |
|
26 |
0.21 |
Jan. 14, 2025 | USD 63.79 | -0.65% |
|
United States |
|
27 |
0.18 |
Jan. 14, 2025 | USD 51.57 | 0.10% |
|
United States |
|
28 |
0.16 |
Jan. 14, 2025 | USD 240.05 | 1.68% |
|
United States |
|
29 |
0.15 |
Jan. 14, 2025 | USD 20.73 | 0.34% |
|
United States |
|
30 |
0.13 |
Jan. 14, 2025 | USD 1.64 | -2.96% |
|
United States |
|
31 |
0.12 |
Jan. 14, 2025 | USD 6.18 | -4.33% |
|
United States |
|
32 |
0.11 |
Jan. 14, 2025 | USD 3.79 | 1.24% |
|
United States |
|
33 |
0.07 |
Jan. 14, 2025 | USD 12.24 | 2.86% |
|
United States |
The Drugstores & Retail Pharmacies company in United States with the highest Price to Sales Ratio (P/S) is National Retail Properties, Inc. (NYSE: NNN) at 8.48.
The Drugstores & Retail Pharmacies company in United States with the lowest Price to Sales Ratio (P/S) is Walgreens Boots Alliance, Inc. (NasdaqGS: WBA) at 0.07.
The top 10 Drugstores & Retail Pharmacies companies in United States by Price to Sales Ratio (P/S) are National Retail Properties, Inc., Lennox International Inc., Johnson & Johnson, Innoviva, Inc., Brady Corporation, Floor & Decor Holdings, Inc., Xponential Fitness, Inc., ANI Pharmaceuticals, Inc., GoodRx Holdings, Inc. and Omnicell, Inc..
The bottom 10 Drugstores & Retail Pharmacies companies in United States by Price to Sales Ratio (P/S) are Walgreens Boots Alliance, Inc., Pilulka Lékárny a.s., Herbalife Nutrition Ltd., Aytu BioPharma, Inc., Albertsons Companies, Inc., Cencora, CVS Health Corporation, Ingles Markets, Incorporated, McKesson Corporation and Biofrontera Inc..